LPCN Reports $24.7M Cash, $3.7M Net Loss, $119K Royalty, Phase 3 PPD Trial Misses Primary Endpoint
Lipocine Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.28
-7.5% in 7d after detection
Post-detection moves
1h
—
1d
-0.8%
3d
-2.5%
7d
-7.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS